Testosterone cypionate was first approved by the FDA for clinical use in the US in 1950. However, it has been used for clinical purposes much before that. In fact, the first human use of testosterone dates back to the early 1900s. In 1937, testosterone cypionate was first synthesized. The drug was used to treat underdeveloped testicles and various types of breast cancer. In 1942, testosterone cypionate was first administered to a patient suffering from a lack of virility. Testosterone cypionate was also used to treat a number of other disorders, including a lack of libido and erectile dysfunction.
The first testosterone cypionate drug manufactured in the US was Testosterone Propionate. This was followed by Testosterone Enanthate. Both these drugs were manufactured by Searle Laboratories. In 1950, the FDA approved testosterone cypionate as a drug for clinical use. In the same year, the drug was marketed by Parke Davis & Company under the name Testosterone Cyclopentylpropionate. In 1952, this drug was first used to treat a patient suffering from a lack of virility. In 1954, a new drug called Testosterone Propionate was marketed. This drug was first used to treat a patient suffering from breast cancer. In 1955, a new drug called Testosterone Enanthate was first marketed. This drug was first used to treat breast cancer.
Today, testosterone cypionate is used to treat a number of conditions. These include lack of virility, underdeveloped testicles, breast cancer, prostate cancer, erectile dysfunction, and low levels of testosterone. The drug has also been used in the treatment of delayed puberty. Most of the testosterone cypionate available in the US is manufactured by Pfizer.
Testosterone cypionate is most commonly used in the treatment of delayed puberty in boys. The dose for this condition is 50 to 100 mg every two to four weeks. The dose for patients suffering from breast cancer is 200 to 400 mg every two to three weeks. The dose for patients suffering from prostate cancer is usually 300 to 600 mg every two to three weeks. The dose for patients suffering from low levels of testosterone is usually 50 to 100 mg every two to four weeks.
The dose for patients suffering from erectile dysfunction is usually 100 to 200 mg every two to three weeks. The dose for patients suffering from low levels of testosterone is usually 50 to 100 mg every two to four weeks. The dose for patients suffering from underdeveloped testicles is usually 50 to 100 mg every two to four weeks.
For patients with kidney problems, the dosage is usually reduced by 50 to 75 percent. To keep safe, make sure to look into details of oral and injectable steroids for sale before buying.